JCR Pharmaceuticals Co Ltd
JCR Pharmaceuticals's GHG Emissions Data Preview
In 2022, JCR Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
JCR Pharmaceuticals has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2022 | 2021 | 2020 | 2019 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
a
a
a
a
a
a
a
aVerified Sources Behind JCR Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore JCR Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into JCR Pharmaceuticals's Operational Emissions
In 2022, the total operational greenhouse gas (GHG) emissions of JCR Pharmaceuticals amounted to 10,985 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2021, the total operational greenhouse gas (GHG) emissions of JCR Pharmaceuticals increased by 49.09%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
JCR Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are JCR Pharmaceuticals's Scope 1 emissions?
In 2022, the total Scope 1 emissions of JCR Pharmaceuticals were 3,315 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2021), JCR Pharmaceuticals's Scope 1 emissions increased by 48.52%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are JCR Pharmaceuticals's Scope 2 emissions?
In 2022, JCR Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 5,266 tCO₂e using the market-based method and 7,670 tCO₂e using the location-based method. a
What methodology does JCR Pharmaceuticals use for Scope 2 reporting?
In 2022, JCR Pharmaceuticals reported its Scope 2 emissions using the market-based method and using the location-based method. a
JCR Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
- Total Scope 2 (Unspecified Calculation Method)
Insights into JCR Pharmaceuticals's Value Chain Emissions
In 2022, JCR Pharmaceuticals reported 79,466 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2022 disclosure of JCR Pharmaceuticals includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2021, reflecting improved emissions accounting practices and greater transparency across the company's value chain a
JCR Pharmaceuticals's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are JCR Pharmaceuticals's Scope 3 emissions?
In 2022, JCR Pharmaceuticals reported total Scope 3 emissions of 79,466 metric tons of CO₂ equivalent (tCO₂e). a
Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a
Compared to the previous year (2021), JCR Pharmaceuticals's Scope 3 emissions remained relatively stable, indicating that JCR Pharmaceuticals 's emissions have plateaued with no significant change in its value chain footprint. a
What categories of Scope 3 emissions does JCR Pharmaceuticals disclose?
In 2022, JCR Pharmaceuticals reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol. a
This reflects a high level of granularity and transparency in the company's emissions reporting.
What are the main sources of JCR Pharmaceuticals's Scope 3 emissions?
In 2022, the largest contributors to JCR Pharmaceuticals's Scope 3 emissions were: a
- Capital Goods (Cat. 2): 39,094 tCO₂e (49.2%)
- Purchased Goods and Services (Cat. 1): 38,635 tCO₂e (48.62%)
- Fuel- and Energy-Related Services (Cat. 3): 1,155 tCO₂e (1.45%)
JCR Pharmaceuticals's Scope 3 Emissions by Categories
Insights into JCR Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2022, JCR Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 3,315 tCO₂e and total revenues of USD 419 millions. This translates into an emissions intensity of 7.92 tCO₂e per millions USD. a
JCR Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does JCR Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2022, JCR Pharmaceuticals reported a Scope 1 emissions intensity of 7.92 tCO₂e per millions USD. Compared to the peer group median of 4.44 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does JCR Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2022, JCR Pharmaceuticals ranked 18 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
JCR Pharmaceuticals is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into JCR Pharmaceuticals's Total Carbon Footprint
In 2022, JCR Pharmaceuticals reported a total carbon footprint of 90,451 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 5.75% increase compared to 2021, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to JCR Pharmaceuticals's total carbon footprint was Scope 3 emissions, accounting for 87.86% of the company's total carbon footprint, followed by Scope 2 emissions at 8.48%. a